Oncogenic Ras pushes (and pulls) cell cycle progression through ERK activation

Methods in Molecular Biology

Volumn 1170, Issue , 2014, Pages 155-163

  Campbell, Paul M ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Cell cycle; Cyclin; ERK; MEK; Proliferation; Raf; Ras

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE;

CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DEATH; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME ACTIVATION; ONCOGENE RAS; PRIORITY JOURNAL; REVIEW; SENESCENCE; SIGNAL TRANSDUCTION;

EID: 84934444413     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-888-2_9     Document Type: Review

References (64)

1. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144(5):646-674
2. Campbell PM, der CJ (2004) Oncogenic Ras and its role in tumor cell invasion and metastasis. Semin Cancer Biol 14(2):105-114
3. Campbell PM, Groehler AL, Lee KM, Ouellette MM, Khazak V, der CJ (2007) K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling. Cancer Res 67(5):2098-2106
4. Choy E, Chiu VK, Silletti J, Feoktistov M, Morimoto T, Michaelson D, Ivanov IE, Philips MR (1999) Endomembrane trafficking of Ras: the CAAX motif targets proteins to the ER and Golgi. Cell 98(1):69-80
5. Shields JM, Pruitt K, McFall A, Shaub A, der CJ (2000) Understanding Ras: 'it ain't over 'til it's over'. Trends Cell Biol 10(4):147-154
6. Quilliam LA, Rebhun JF, Castro AF (2002) A growing family of guanine nucleotide exchange factors is responsible for activation of Ras-family GTPases. Prog Nucleic Acid Res Mol Biol 71:391-444
7. Feig LA, Buchsbaum RJ (2002) Cell signaling: life or death decisions of ras proteins. Curr Biol 12(7):R259-R261
8. Wolthuis RM, Bos JL (1999) Ras caught in another affair: the exchange factors for Ral. Curr Opin Genet Dev 9(1):112-117
9. Bivona TG, Philips MR (2003) Ras pathway signaling on endomembranes. Curr Opin Cell Biol 15(2):136-142
10. Downward J (2003) Targeting RAS signalling pathways in cancer therapy. Nat Rev Cancer 3(1):11-22
11. Bos JL (1989) ras oncogenes in human cancer: a review. Cancer Res 49(17):4682-4689
12. Barbacid M (1987) ras genes. Annu Rev Biochem 56:779-827
13. Janes PW, Daly RJ, De Fazio A, Sutherland RL (1994) Activation of the Ras signalling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 9(12):3601-3608
14. Clark GJ, der CJ (1995) Aberrant function of the Ras signal transduction pathway in human breast cancer. Breast Cancer Res Treat 35(1):133-144
15. Tzahar E, Yarden Y (1998) The ErbB-2/HER2 oncogenic receptor of adenocarcinomas: from orphanhood to multiple stromal ligands. Biochim Biophys Acta 1377(1):M25-M37
16. Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, De Pinho RA, Panayotatos N, Cobb MH, Yancopoulos GD (1991) ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell 65(4):663-675
17. Sturgill TW, Ray LB, Erikson E, Maller JL (1988) Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 334(6184):715-718
18. Terai K, Matsuda M (2005) Ras binding opens c-Raf to expose the docking site for mitogenactivated protein kinase kinase. EMBO Rep 6(3):251-255
19. Sun H, Charles CH, Lau LF, Tonks NK (1993) MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo. Cell 75(3):487-493
20. Karlsson M, Mathers J, Dickinson RJ, Mandl M, Keyse SM (2004) Both nuclear-cytoplasmic shuttling of the dual specificity phosphatase MKP-3 and its ability to anchor MAP kinase in the cytoplasm are mediated by a conserved nuclear export signal. J Biol Chem 279(40):41882-41891
21. Shore P, Sharrocks AD (1994) The transcription factors Elk-1 and serum response factor interact by direct protein-protein contacts mediated by a short region of Elk-1. Mol Cell Biol 14(5):3283-3291
22. Shin SY, Kim CG, Lim Y, Lee YH (2011) The ETS family transcription factor ELK-1 regulates induction of the cell cycle-regulatory gene p21 (Waf1/Cip1) and the BAX gene in sodium arsenite-exposed human keratinocyte HaCaT cells. J Biol Chem 286(30):26860-26872
23. Hipskind RA, Roa VN, Muller C G F, Raddy E S P, Nordheim A (1991) Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF. Nature 354(6354):531-534
24. Patki M, Chari V, Sivakumaran S, Gonit M, Trumbly R, Ratnam M (2013) The ETS domain transcription factor ELK1 directs a critical component of growth signaling by the androgen receptor in prostate cancer cells. J Biol Chem 288(16):11047-11065
25. Reddy ES, Rao VN (1991) erg, an ets-related gene, codes for sequence-specific transcriptional activators. Oncogene 6(12):2285-2289
26. Aplin AE, Stewart SA, Assoian RK, Juliano RL (2001) Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1. J Cell Biol 153(2):273-282
27. Anjum R, Blenis J (2008) The RSK family of kinases: emerging roles in cellular signalling. Nat Rev Mol Cell Biol 9(10):747-758
28. Zhao Y, Bjorbaek C, Weremowicz S, Morton CC, Moller DE (1995) RSK3 encodes a novel pp90rsk isoform with a unique N-terminal sequence: growth factor-stimulated kinase function and nuclear translocation. Mol Cell Biol 15(8):4353-4363
29. Bonni A, Brunet A, West AE, Datta SR, Takasu MA, Greenberg ME (1999) Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science 286(5443):1358-1362
30. Cagnol S, Chambard JC (2010) ERK and cell death: mechanisms of ERK-induced cell death-apoptosis, autophagy and senescence. FEBS J 277(1):2-21
31. Versteeg HH, Borensztajn KS, Kerver ME, Ruf W, Reitsma PH, Spek CA, Peppelenbosch MP (2008) TF: FVIIa-specific activation of CREB upregulates proapoptotic proteins via proteaseactivated receptor-2. J Thromb Haemost 6(9):1550-1557
32. Balmanno K, Cook SJ (2009) Tumour cell survival signalling by the ERK1/2 pathway. Cell Death Differ 16(3):368-377
33. Palmer A, Gavin AC, Nebreda AR (1998) A link between MAP kinase and p34 (cdc2)/cyclin B during oocyte maturation: p90 (rsk) phosphorylates and inactivates the p34 (cdc2) inhibitory kinase Myt1. EMBO J 17(17):5037-5047
34. Nakajima H, Yonemura S, Murata M, Nakamura N, Piwnica-Worms H, Nishida E (2008) Myt1 protein kinase is essential for Golgi and ER assembly during mitotic exit. J Cell Biol 181(1):89-103
35. Terada Y, Tatsuka M, Jinno S, Okayama H (1995) Requirement for tyrosine phosphorylation of Cdk4 in G1 arrest induced by ultraviolet irradiation. Nature 376(6538):358-362
36. Iavarone A, Massague J (1997) Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15. Nature 387(6631):417-422
37. Hoffmann I, Draetta G, Karsenti E (1994) Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J 13(18):4302-4310
38. Goodrich DW, Wang NP, Qian YW, Lee EY, Lee WH (1991) The retinoblastoma gene product regulates progression through the G1 phase of the cell cycle. Cell 67(2):293-302
39. Chellappan SP, Hiebert S, Mudryj M, Horowitz JM, Nevins JR (1991) The E2F transcription factor is a cellular target for the RB protein. Cell 65(6):1053-1061
40. Nevins JR (2001) The Rb/E2F pathway and cancer. Hum Mol Genet 10(7):699-703
41. Aktas H, Cai H, Cooper GM (1997) Ras links growth factor signaling to the cell cycle machinery via regulation of cyclin D1 and the Cdk inhibitor p27KIP1. Mol Cell Biol 17(7):3850-3857
42. Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio A, Califano D, Vinci F, Chiappetta G, Tsichlis P, Bellacosa A, Fusco A, Santoro M (2002) Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 8(10):1136-1144
43. Shin I, Yakes FM, Rojo F, Shin N-Y, Bakin AV, Baselga J, Arteaga CL (2002) PKB/Akt mediates cell-cycle progression by phosphorylation of p27Kip1 at threonine 157 and modulation of its cellular localization. Nat Med 8(10):1145-1152
44. Liang J, Zubovitz J, Petrocelli T, Kotchetkov R, Connor MK, Han K, Lee J-H, Ciarallo S, Catzavelos C, Beniston R, Franssen E, Slingerland JM (2002) PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest. Nat Med 8(10):1153-1160
45. Donovan JC, Milic A, Slingerland JM (2001) Constitutive MEK/MAPK activation leads to p27 (Kip1) deregulation and antiestrogen resistance in human breast cancer cells. J Biol Chem 276(44):40888-40895
46. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell RG (1995) Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J Biol Chem 270(40):23589-23597
47. Preston GA, Srinivasan D, Barrett JC (2000) Apoptotic response to growth factor deprivation involves cooperative interactions between c-Fos and p300. Cell Death Differ 7(2):215-226
48. Burch PM, Yuan Z, Loonen A, Heintz NH (2004) An extracellular signal-regulated kinase 1- and 2-dependent program of chromatin trafficking of c-Fos and Fra-1 is required for cyclin D1 expression during cell cycle reentry. Mol Cell Biol 24(11):4696-4709
49. Draetta G, Beach D (1988) Activation of cdc2 protein kinase during mitosis in human cells: cell cycle-dependent phosphorylation and subunit rearrangement. Cell 54(1):17-26
50. Wang R, He G, Nelman-Gonzalez M, Ashorn CL, Gallick GE, Stukenberg PT, Kirschner MW, Kuang J (2007) Regulation of Cdc25C by ERK-MAP kinases during the G2/M transition. Cell 128(6):1119-1132
51. Hoffmann I, Clarke PR, Marcote MJ, Karsenti E, Draetta G (1993) Phosphorylation and activation of human cdc25-C by cdc2-cyclin B and its involvement in the self-amplification of MPF at mitosis. EMBO J 12(1):53-63
52. Malumbres M, Barbacid M (2005) Mammalian cyclin-dependent kinases. Trends Biochem Sci 30(11):630-641
53. Ravitz MJ, Wenner CE (1997) Cyclindependent kinase regulation during G1 phase and cell cycle regulation by TGF-beta. Adv Cancer Res 71:165-207
54. Lecanda J, Ganapathy V, D'Aquino-Ardalan C, Evans B, Cadacio C, Ayala A, Gold LI (2009) TGFβ prevents proteasomal degradation of the cyclin-dependent kinase inhibitor p27 kip1 for cell cycle arrest. Cell Cycle 8(5):742-756
55. Hannon GJ, Beach D (1994) p15INK4B is a potential effector of TGF-beta-induced cell cycle arrest. Nature 371(6494):257-261
56. Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, Lam EW, Burgering BM, Raaijmakers JA, Lammers JW, Koenderman L, Coffer PJ (2000) Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27 (KIP1). Mol Cell Biol 20(24):9138-9148
57. Malumbres M, Perez De Castro I, Hernandez MI, Jimenez M, Corral T, Pellicer A (2000) Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15 (INK4b). Mol Cell Biol 20(8):2915-2925
58. Gomis RR, Alarcon C, Nadal C, Van Poznak C, Massague J (2006) C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells. Cancer Cell 10(3):203-214
59. Franza BR Jr, Maruyama K, Garrels JI, Ruley HE (1986) In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes. Cell 44(3):409-418
60. Hirakawa T, Ruley HE (1988) Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene. Proc Natl Acad Sci U S A 85(5):1519-1523
61. Samuels ML, Weber MJ, Bishop JM, McMahon M (1993) Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradioldependent human raf-1 protein kinase. Mol Cell Biol 13(10):6241-6252
62. La Baer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E (1997) New functional activities for the p21 family of CDK inhibitors. Genes Dev 11(7):847-862
63. Sewing A, Wiseman B, Lloyd AC, Land H (1997) High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol 17(9):5588-5597
64. Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M (1997) Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 17(9):5598-5611